Syndax Pharmaceuticals, Inc. logo SNDX - Syndax Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 20
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $41.50 DETAILS
HIGH: $46.00
LOW: $37.00
MEDIAN: $41.50
CONSENSUS: $41.50
UPSIDE: 106.36%

Profitability Ratios

Ratio Value
GP Margin 96.0%
EBIT Margin -146.0%
EBITDA Margin -146.0%
Operating Margin -158.4%
Pretax Margin -165.6%
Cont. Ops Margin -165.6%
Net Margin -165.6%
Bottom Line Margin -165.6%

Liquidity Ratios

Ratio Value
Current Ratio 4.40
Quick Ratio 4.12
Solvency Ratio -0.614
Cash Ratio 1.12

Valuation Ratios

Ratio Value
Price/Earnings
-6.38
Hist. avg: 45.7
Peers avg: 13.0
PEG Ratio 0.54
Forward PEG 0.54
Price/Book 28.16
Price/Sales 10.56
Price/FCF -5.63
Price/Op Cash Flow -5.64

Debt Ratios

Ratio Value
Debt/Assets 0.6541
Debt/Equity 5.3610
Debt/Capital 0.8428
Long-Term Debt/Capital 0.8422
Financial Leverage 8.20

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.38
Operating Cash Flow Ratio -2.689
Operating Cash Flow/Sales -187.4%
Free Cash Flow/Operating Cash Flow 100.1%

Coverage Ratios

Ratio Value
Debt Service Coverage -7.35
Interest Coverage -8.0830
Short-Term Operating Cash Flow Coverage -684.28
Operating Cash Flow Coverage -0.93
Capital Expenditure Coverage -1727.17
Dividend + Capital Expenditure Coverage -1727.17

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 1.99
EPS -3.295
Debt/Share 4.3898
Cash/Share 4.55
Book Value/Share 0.75
Tangible BV/Share 0.75
Equity/Share 0.75
Operating Cash Flow/Share -3.728
Capital Expenditure/Share 0.002
FCF/Share -3.731

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 1.045
Price/Fair Value 28.16
Debt/Market Cap 0.1898
Effective Tax Rate 0.0%
Enterprise Value Multiple -8.07